NIAID is committed to conducting the research necessary to confront HIV/AIDS. Volunteer participation in a clinical research study helps NIAID better understand HIV, find promising new tools to prevent HIV infection including a preventive vaccine, and develop new and more effective treatment strategies.

The following are select studies being conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The links lead to full study titles and descriptions:

• Effect of Early Antiretroviral Therapy on Maintenance of Immune Cell Function (NCT00039689)
• Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy (NCT00286767)
• Leukapheresis Procedures for Research on HCV-infected and HIV/HCV Co-infected Patients (NCT00076427)
• Leukapheresis Procedures to Study Long-term Non-progressors (NCT00029445)
• Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy (NCT00326482)
• Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men (NCT00865566)
• Screening Healthy Volunteers for HIV Vaccine Research Studies (NCT00031304)
• Strategic Timing of Antiretroviral Treatment (NCT00867048)

NIAID supports six clinical trial networks that conduct domestic and international human studies focused on HIV/AIDS:

• The AIDS Clinical Trials Group (ACTG)
• The HIV Prevention Trials Network (HPTN)
• The HIV Vaccine Trials Network (HVTN)
• The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group
• The International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
• The Microbicide Trials Network (MTN)

See a complete list of NIAID-supported HIV/AIDS clinical research studies being conducted elsewhere in the Washington, DC, area, throughout the United States, and around the world.

Read more about NIAID HIV/AIDS research.

Help NIAID raise awareness about the need for an HIV vaccine.